Daniel Schumacher - 20 May 2026 Form 4 Insider Report for Proto Labs Inc (PRLB)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
22 May 2026, 16:12:33 UTC
Prior SEC filing
27 Feb 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ W. Morgan Burns, Attorney-in-Fact

Key filing fact

Daniel Schumacher filed Form 4 for Proto Labs Inc (PRLB) on 22 May 2026.

Key facts

  • This page summarizes Daniel Schumacher's Form 4 filing for Proto Labs Inc (PRLB).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 22 May 2026, 16:12.

Change

  • Previous filing in this sequence was filed on 27 Feb 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001894753 Primary reporting owner

Schumacher Daniel

Relationship
Chief Financial Officer
Address
5540 PIONEER CREEK DRIVE, MAPLE PLAIN
Signature
/s/ W. Morgan Burns, Attorney-in-Fact
Signature date
22 May 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PRLB transaction

Common Stock

Tax liability

Transaction value
Shares
-255
Change %
-0.56%
Price
$71.13*
Shares after
45,019
Date
20 May 2026
Ownership
Direct
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .